Contact This Study Your name* First Your email* Your phone numberYour contact information will be sent to a team atYour contact information will be sent to a team at Your information will be kept confidential and will never be sold or shared with outside vendors.Study TitleA Double Blind, Randomized, Placebo-Controlled, Multicenter Phase IIa, Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab in IgA Nephropathy – IGNAZHiddenStudy Email HiddenStudy Marketing TitleIGNAZHiddenSite NameHiddenSite LocationMontana, Bulgaria.HiddenUser Role Sign up to get NephCure’s latest updates. SIGN UP Email(Required) EmailThis field is for validation purposes and should be left unchanged.